The promise of using histone deacetylase inhibitors in combination treatment against breast cancer and other solid tumors.

Chin Clin Oncol

Tumour Suppressor Signalling Networks Laboratory, UCL Cancer Institute, University College London, London, UK.

Published: February 2017

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2017.01.05DOI Listing

Publication Analysis

Top Keywords

promise histone
4
histone deacetylase
4
deacetylase inhibitors
4
inhibitors combination
4
combination treatment
4
treatment breast
4
breast cancer
4
cancer solid
4
solid tumors
4
promise
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!